Number of the records: 1  

Prospects for immunotherapy of MHC class I-deficient tumours

  1. 1. 0191552 - UMG-J 20033051 RIV CZ eng J - Journal Article
    Bubeník, Jan
    Prospects for immunotherapy of MHC class I-deficient tumours.
    Folia Biologica. Roč. 49, č. 3 (2003), s. 95-99 ISSN 0015-5500
    Institutional research plan: CEZ:AV0Z5052915
    Keywords : MHC class I * immunotherapy
    Subject RIV: FD - Oncology ; Hematology
    Impact factor: 0.527, year: 2003

    More attention should be paid to the MHC class I status of the neoplasms during the elaboration of tumour immunotherapy protocols with regard to the possible cytokine therapy. Prospectively, the therapeutic role of the induction of MHC class I expression by demethylation and acetylation agents prior to or simultaneously with the immunotherapy should also be investigated.
    Permanent Link: http://hdl.handle.net/11104/0087295